S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

ACADIA Pharmaceuticals (ACAD) Short Interest Ratio & Short Volume

$17.19
+0.11 (+0.64%)
(As of 04/17/2024 ET)

ACADIA Pharmaceuticals Short Interest Data

Current Short Volume
11,200,000 shares
Previous Short Volume
10,630,000 shares
Change Vs. Previous Month
+5.36%
Dollar Volume Sold Short
$207.09 million
Short Interest Ratio / Days to Cover
6.1
Last Record Date
March 31, 2024
Outstanding Shares
164,770,000 shares
Percentage of Shares Shorted
6.80%
Today's Trading Volume
1,027,805 shares
Average Trading Volume
1,770,983 shares
Today's Volume Vs. Average
58%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling ACADIA Pharmaceuticals ?

Sign up to receive the latest short interest report for ACADIA Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ACAD Short Interest Over Time

ACAD Days to Cover Over Time

ACAD Percentage of Float Shorted Over Time

ACADIA Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202411,200,000 shares $207.09 million +5.4%N/A6.1 $18.49
3/15/202410,630,000 shares $196.44 million -1.7%N/A5.8 $18.48
2/29/202410,810,000 shares $251.22 million +14.8%N/A5.5 $23.24
2/15/20249,420,000 shares $237.20 million +22.7%N/A5.3 $25.18
1/31/20247,680,000 shares $198.99 million -5.3%N/A4.4 $25.91
1/15/20248,110,000 shares $233.00 million +2.5%N/A4.6 $28.73
12/31/20237,910,000 shares $247.66 million +2.9%N/A4.6 $31.31
12/15/20237,690,000 shares $219.78 million -0.5%N/A4 $28.58
11/30/20237,730,000 shares $172.22 million -0.8%N/A4.8 $22.28
11/15/20237,790,000 shares $175.82 million +3.3%N/A5 $22.57
10/31/20237,540,000 shares $170.18 million +4.0%N/A4.7 $22.57
10/15/20237,250,000 shares $167.77 million -19.1%N/A4.4 $23.14
9/30/20238,960,000 shares $186.73 million -16.3%N/A4.8 $20.84
9/15/202310,700,000 shares $264.50 million +5.1%N/A6.6 $24.72
8/31/202310,180,000 shares $275.06 million +4.2%N/A6.5 $27.02
8/15/20239,770,000 shares $280.59 million +10.3%N/A6 $28.72
7/31/20238,860,000 shares $259.07 million +0.9%N/A5.3 $29.24
7/15/20238,780,000 shares $282.54 million +5.0%N/A5.7 $32.18
6/30/20238,360,000 shares $200.22 million -10.9%N/A6.3 $23.95
6/15/20239,380,000 shares $228.78 million -6.6%N/A7 $24.39
5/31/202310,040,000 shares $235.94 million +0.7%N/A6.5 $23.50
5/15/20239,970,000 shares $220.54 million +3.3%N/A6.1 $22.12
4/30/20239,650,000 shares $205.83 million +0.4%6.0%6.1 $21.33
4/15/20239,610,000 shares $172.88 million +17.5%6.0%6 $17.99
3/31/20238,180,000 shares $153.95 million -3.8%5.1%5.2 $18.82
3/15/20238,500,000 shares $168.73 million +5.7%5.3%5.6 $19.85
2/28/20238,040,000 shares $166.35 million -0.3%5.0%6.3 $20.69
2/15/20238,060,000 shares $152.90 million -0.5%5.1%7.1 $18.97
1/31/20238,100,000 shares $154.14 million +1.1%5.1%6.9 $19.03
1/15/20238,010,000 shares $147.38 million -4.5%5.0%6.5 $18.40
12/30/20228,390,000 shares $133.57 million -3.6%5.3%6.8 $15.92
12/15/20228,700,000 shares $131.11 million -10.0%5.5%6.6 $15.07
11/30/20229,670,000 shares $150.66 million +7.0%6.1%7 $15.58
11/15/20229,040,000 shares $141.84 million -13.4%5.7%6.2 $15.69
10/31/202210,440,000 shares $167.35 million +9.7%6.5%6.7 $16.03
10/15/20229,520,000 shares $149.65 million -1.7%6.0%6.1 $15.72
9/30/20229,680,000 shares $158.36 million +0.8%6.1%5.9 $16.36
9/15/20229,600,000 shares $175.39 million -3.7%6.0%5.4 $18.27
8/31/20229,970,000 shares $163.81 million -1.5%6.3%3.9 $16.43
8/15/202210,120,000 shares $167.99 million +4.7%6.4%3.9 $16.60
Top 5 Tech Stocks to Buy for 2024 (Ad)

Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk.

Click here to sign up for our free report & newsletter

ACAD Short Interest - Frequently Asked Questions

What is ACADIA Pharmaceuticals' current short interest?

Short interest is the volume of ACADIA Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 11,200,000 shares of ACAD short. Learn More on ACADIA Pharmaceuticals' current short interest.

What is a good short interest ratio for ACADIA Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACAD shares currently have a short interest ratio of 6.0. Learn More on ACADIA Pharmaceuticals's short interest ratio.

Which institutional investors are shorting ACADIA Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ACADIA Pharmaceuticals: Goldman Sachs Group Inc., GTS Securities LLC, Torno Capital LLC, Barclays PLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Citadel Advisors LLC, Goldman Sachs Group Inc., Worth Venture Partners LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is ACADIA Pharmaceuticals' short interest increasing or decreasing?

ACADIA Pharmaceuticals saw a increase in short interest in March. As of March 31st, there was short interest totaling 11,200,000 shares, an increase of 5.4% from the previous total of 10,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ACADIA Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ACADIA Pharmaceuticals: MoonLake Immunotherapeutics (16.21%), HUTCHMED (China) Limited (0.29%), MorphoSys AG (1.08%), Arrowhead Pharmaceuticals, Inc. (7.16%), Indivior PLC (0.13%), Janux Therapeutics, Inc. (11.58%), IDEAYA Biosciences, Inc. (14.29%), Amicus Therapeutics, Inc. (11.00%), Xenon Pharmaceuticals Inc. (3.66%), Evotec SE (0.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short ACADIA Pharmaceuticals stock?

Short selling ACAD is an investing strategy that aims to generate trading profit from ACADIA Pharmaceuticals as its price is falling. ACAD shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ACADIA Pharmaceuticals?

A short squeeze for ACADIA Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACAD, which in turn drives the price of the stock up even further.

How often is ACADIA Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACAD, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ACAD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners